United States Cardiac Implantable Electronic Devices Market Growth 2024-2031: Pacemakers, ICDs, CRTs, and Innovations in Leadless, MRI-Compatible, and Remote Monitoring Technologies

Cardiac Implantable Electronic Devices Market is valued at a significant CAGR during the forecast period (2024-2031). As per DataM Intelligence Database.

Cardiac Implantable Electronic Devices (CIED) Market refers to the global industry involved in the development, manufacturing, and commercialization of medical devices that are surgically implanted to manage heart rhythm disorders and cardiac conditions. These devices include pacemakers, implantable cardioverter defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices. CIEDs help regulate abnormal heart rhythms, improve cardiac function, and reduce the risk of complications associated with arrhythmias and heart failure, while innovations in device design, miniaturization, and connectivity continue to enhance patient outcomes and monitoring capabilities.

📌 Download Sample Report to Identify Emerging Deals & Opportunities in the Cardiac Implantable Electronic Devices Market Landscape:- https://datamintelligence.com/download-sample/cardiac-implantable-electronic-devices-market?rk

☛ Cardiac Implantable Electronic Devices Market Recent Developments 2025:

United States: Recent Industry Developments
✅ January 2025 - In January 2025, Elutia launched EluPro, a regenerative biomatrix device cleared for use across all major CIED products, including pacemakers and implantable defibrillators. It combines soft biomaterial with antibiotics to reduce complications and support healing.

✅ March 2025 - In March 2025, Medtronic introduced the Aurora EV-ICDTM MRI system, marking a significant advancement in extravascular implantable cardioverter defibrillator technology.

✅ May 2025 - In May 2025, MicroPort CRM initiated the PIANO study to assess the safety and performance of its pacemakers and defibrillators, including ICDs and CRT-Ds, in line with European Medical Device Regulation standards.

Japan: Recent Industry Developments
✅ March 2025 - In March 2025, Medtronic launched the Aurora EV-ICDTM MRI system in Japan, offering a new approach to defibrillation therapy with MRI compatibility.

✅ May 2025 - In May 2025, MicroPort CRM commenced the PIANO study in Japan to evaluate the safety and performance of its pacemakers and defibrillators, including ICDs and CRT-Ds, ensuring compliance with European Medical Device Regulation standards.

✅ July 2025 - In July 2025, the Japanese cardiovascular devices market is projected to reach USD 4.19 billion by 2030, driven by an aging population and advancements in diagnostic and monitoring devices.

☛ Cardiac Implantable Electronic Devices Market Trends:

The Cardiac Implantable Electronic Devices (CIED) Market is experiencing steady growth due to the increasing prevalence of cardiovascular diseases, rising geriatric population, and growing awareness of cardiac health. CIEDs-including pacemakers, implantable cardioverter defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices-help manage arrhythmias, heart failure, and other cardiac conditions. Advances in device miniaturization, battery longevity, and wireless connectivity are driving adoption in both developed and emerging markets.

Technological innovations such as leadless pacemakers, subcutaneous ICDs, and MRI-compatible devices are improving patient safety, comfort, and monitoring capabilities. Integration with remote monitoring and digital health platforms allows real-time data tracking and personalized therapy adjustments. Strategic partnerships between medical device manufacturers and healthcare providers, along with supportive reimbursement policies, are further propelling the market. Increasing focus on early detection, minimally invasive procedures, and home-based cardiac care is expected to sustain market growth globally.

☛ Cardiac Implantable Electronic Devices Market Competitve Landscape:

Abbott, Medtronic plc, Boston Scientific Corporation, Biotronic AG, Stryker, Microport Scientific Corporation, Koninklijke Philips N.V., Lepu Medical Technology (Beijing)Co.,Ltd., MEDICO S.R.L., and Vitatron among others.

Research Methodology

We follow a hybrid research approach, combining qualitative insights with rigorous quantitative analysis to deliver reliable and comprehensive market intelligence. Our process begins with extensive secondary research, drawing on trusted industry reports, proprietary databases, and credible market sources. This is then reinforced through targeted primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.

📌 Request a Customized Market Report - Tailored insights to match your business goals: https://datamintelligence.com/customize/cardiac-implantable-electronic-devices-market

☛ Segment Covered in the Cardiac Implantable Electronic Devices Market:

By Product: Long Acting Biosimilars | Rapid Acting Biosimilars | Premixed Biosimilars

By Indication: Type 1 Diabetes | Type 2 Diabetes

By Distribution Channel: Hospital Pharmacies | Retail Pharmacies | Online Pharmacies

☛ This Report Includes:

✔ Comprehensive go-to-market strategies with actionable insights.

✔ Unbiased evaluation of overall market performance.

✔ Deep-dive analysis into development trends, competitive landscape, supply-demand dynamics, YoY growth, benchmarking, vendor mapping, market access, and overall progress.

✔ Tailored regional and country-level reports with detailed localized analysis available on request.

✔ Identification of niche segments and high-growth regions presenting strong opportunities.

✔ Accurate regional forecasts using both top-down and bottom-up approaches.

📌 Get Corporate Access to Live Cardiac Implantable Electronic Devices Industry Intelligence Database: https://www.datamintelligence.com/buy-now-page?report=cardiac-implantable-electronic-devices-market

☛ Regional Analysis for Cardiac Implantable Electronic Devices Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

☛ Frequently asked questions:

➠ What is the global sales, production, consumption, import, and export value of the Cardiac Implantable Electronic Devices Market?
➠ Who are the key global manufacturers, and what is their operational performance?
➠ What are the major opportunities and threats in the global Cardiac Implantable Electronic Devices Market?
➠ Which product types or end-users show the most growth potential and market share?
➠ What challenges and constraints are impacting the Cardiac Implantable Electronic Devices Market?
➠ What sales, marketing, and distribution channels are used globally?

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.